Malignant Hyperthermia Like Manifestations during Management of Refractory Status Epilepticus

被引:0
作者
Srinivas, Deepti [1 ,5 ]
Keshavan, Venkatesh [2 ]
Kamath, Vikram [3 ]
Manmadhan, Manju [4 ]
机构
[1] Apollo Hosp, Dept Neuroanaesthesia & Crit Care, Bangalore, Karnataka, India
[2] Khoula Hosp, Dept Anaesthesiol & Crit Care, Muscat, Oman
[3] Apollo Hosp, Dept Neurol, Bangalore, Karnataka, India
[4] Rajagiri Hosp, Dept Anaesthesia & Neurocrit Care, Kochi, Kerala, India
[5] Apollo Hosp, Dept Neuroanaesthesia & Crit Care, BG Rd, Bangalore 560029, Karnataka, India
关键词
status epilepticus; malignant hyperthermia; delayed malignant hyperthermia; isoflurane; DANTROLENE;
D O I
10.1055/s-0042-1756433
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Management of refractory status epilepticus is challenging for a neurointensivist consequent to systemic complexities associated with various drugs and modalities involved in its treatment. We report one such case that manifested with multiple signs of malignant hyperthermia following use of isoflurane to control seizures. However, the delayed and random occurrence of the signs and negative genetic test report raises doubts regarding the final diagnosis. Delayed presentation of malignant hyperthermia has been reported earlier. Unavailability of dantrolene sodium handily is a major hurdle in treating such cases. We enumerate management of the patient in our intensive care unit.
引用
收藏
页码:51 / 53
页数:3
相关论文
共 10 条
[1]   Atypical presentation of malignant hyperthermia [J].
Evans, TJ ;
Parent, CM ;
McGunigal, MP .
ANESTHESIOLOGY, 2002, 97 (02) :507-508
[2]   Delayed Malignant Hyperthermia After Routine Coronary Artery Bypass [J].
Firstenberg, Michael ;
Abel, Erik ;
Blais, Danielle ;
Andritsos, Michael .
ANNALS OF THORACIC SURGERY, 2010, 89 (03) :947-948
[3]  
Gupta PK, 2017, BJA EDUC, V17, P249, DOI 10.1093/bjaed/mkw079
[4]   A suspected malignant hyperthermia managed without dantrolene sodium [J].
Koo, Bon-Sung ;
Kim, Young-Kwon ;
Kim, Sang-Hyun ;
Lee, Jeong-Seok ;
Kim, Yong-Ik .
KOREAN JOURNAL OF ANESTHESIOLOGY, 2014, 67 :S81-S82
[5]   A CLINICAL GRADING SCALE TO PREDICT MALIGNANT HYPERTHERMIA SUSCEPTIBILITY [J].
LARACH, MG ;
LOCALIO, AR ;
ALLEN, GC ;
DENBOROUGH, MA ;
ELLIS, FR ;
ANAES, FRC ;
GRONERT, GA ;
KAPLAN, RF ;
MULDOON, SM ;
NELSON, TE ;
ORDING, H ;
ROSENBERG, H ;
WAUD, BE ;
WEDEL, DJ .
ANESTHESIOLOGY, 1994, 80 (04) :771-779
[6]   Treatment of Malignant Hyperthermia without Dantrolene in a 14-year-old Boy [J].
Liu, Shu-Ting ;
Liu, Li-Fei ;
Wang, Shou-Yong .
CHINESE MEDICAL JOURNAL, 2017, 130 (06) :755-756
[7]   Delayed onset of malignant hyperthermia without creatine kinase elevation in a geriatric, ryanodine receptor type 1 gene compound heterozygous patient [J].
Newmark, Jordan L. ;
Voelkel, Maria ;
Brandom, Barbara W. ;
Wu, John .
ANESTHESIOLOGY, 2007, 107 (02) :350-353
[8]   Malignant hyperthermia: An Indian perspective [J].
Ramanujam, Mukundan ;
Gulati, Sweta ;
Tyagi, Asha .
JOURNAL OF ANAESTHESIOLOGY CLINICAL PHARMACOLOGY, 2019, 35 (04) :557-558
[9]   Rare postoperative delayed malignant hyperthermia after off-pump coronary bypass surgery and brief review of literature [J].
Raut, Monish S. ;
Kar, Sibashankar ;
Maheshwari, Arun ;
Shivnani, Ganesh ;
Kumar, Arun ;
Daniel, Elvin ;
Joshi, Sandeep ;
Motihar, Amit ;
Gupta, Priyanka .
ANNALS OF CARDIAC ANAESTHESIA, 2016, 19 (02) :357-362
[10]   The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol [J].
Shorvon, Simon ;
Ferlisi, Monica .
BRAIN, 2011, 134 :2802-2818